• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可逆电穿孔治疗胰腺癌肝转移:一例报告。

Irreversible electroporation for liver metastasis from pancreatic cancer: A case report.

作者信息

Ma Yang-Yang, Shi Juan-Juan, Chen Ji-Bing, Xu Ke-Chen, Niu Li-Zhi

机构信息

Central Laboratory, Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.

Department of Oncology, Fuda Cancer Hospital, Jinan University, Guangzhou 510665, Guangdong Province, China.

出版信息

World J Clin Cases. 2020 Jan 26;8(2):390-397. doi: 10.12998/wjcc.v8.i2.390.

DOI:10.12998/wjcc.v8.i2.390
PMID:32047790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7000941/
Abstract

BACKGROUND

Pancreatic cancer has a poor prognosis; 40%-50% of patients have liver metastases at the time of initial diagnosis and only 15%-20% undergo surgical resection. Irreversible electroporation (IRE) is a new, non-thermal local ablation method for solid tumors, which can induce cell membrane permeabilization, resulting in unrecoverable nanoscale perforation and apoptotic cell death without damaging the structural components of tissues.

CASE SUMMARY

We report the case of a 66-year-old female patient with liver metastasis from pancreatic cancer with a pathological diagnosis of poorly differentiated adenocarcinoma. Carbohydrate antigen 19-9 was elevated to 420.3 U/mL. Computed tomography showed a pancreas mass of 2.7 cm × 2.5 cm and single liver metastasis of 1.4 cm × 1.1 cm in the S6 area. The patient underwent IRE and arterial infusion chemotherapy and received tegafur. The therapeutic effect of the combination treatment has been evaluated as complete response. To date, the patient has survived for > 12 mo and is receiving tegafur as maintenance therapy (at the time this case report was written).

CONCLUSION

IRE plus arterial infusion chemotherapy and tegafur may be synergistic, providing a reference for treating liver metastasis from pancreatic cancer.

摘要

背景

胰腺癌预后较差;40% - 50%的患者在初诊时已有肝转移,仅15% - 20%的患者接受手术切除。不可逆电穿孔(IRE)是一种用于实体瘤的新型非热局部消融方法,可诱导细胞膜通透性增加,导致不可恢复的纳米级穿孔和凋亡性细胞死亡,而不损害组织的结构成分。

病例摘要

我们报告了一例66岁女性胰腺癌肝转移患者,病理诊断为低分化腺癌。糖类抗原19 - 9升高至420.3 U/mL。计算机断层扫描显示胰腺肿块大小为2.7 cm×2.5 cm,肝脏S6区有一个1.4 cm×1.1 cm的单发转移灶。该患者接受了IRE和动脉灌注化疗,并接受替加氟治疗。联合治疗的疗效评估为完全缓解。迄今为止,患者已存活超过12个月,目前正在接受替加氟维持治疗(撰写本病例报告时)。

结论

IRE联合动脉灌注化疗和替加氟可能具有协同作用,为治疗胰腺癌肝转移提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/55bf10f5b658/WJCC-8-390-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/190551e6d899/WJCC-8-390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/71183d7fe397/WJCC-8-390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/764415291c99/WJCC-8-390-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/4b3b1fcfd9db/WJCC-8-390-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/55bf10f5b658/WJCC-8-390-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/190551e6d899/WJCC-8-390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/71183d7fe397/WJCC-8-390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/764415291c99/WJCC-8-390-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/4b3b1fcfd9db/WJCC-8-390-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d28/7000941/55bf10f5b658/WJCC-8-390-g005.jpg

相似文献

1
Irreversible electroporation for liver metastasis from pancreatic cancer: A case report.不可逆电穿孔治疗胰腺癌肝转移:一例报告。
World J Clin Cases. 2020 Jan 26;8(2):390-397. doi: 10.12998/wjcc.v8.i2.390.
2
Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.经皮不可逆电穿孔治疗局部晚期和复发性胰腺癌(PANFIRE-2):一项多中心、前瞻性、单臂、二期研究。
Radiology. 2020 Jan;294(1):212-220. doi: 10.1148/radiol.2019191109. Epub 2019 Nov 5.
3
Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.不可逆电穿孔消融在切缘增强中的辅助治疗应用:安全性和有效性。
J Surg Res. 2020 Feb;246:260-268. doi: 10.1016/j.jss.2019.06.010. Epub 2019 Oct 11.
4
Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.经皮不可逆电穿孔消融局部进展期胰腺癌:PANFIRE 研究的 I/II 期结果。
Radiology. 2017 Feb;282(2):585-597. doi: 10.1148/radiol.2016152835. Epub 2016 Sep 6.
5
The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.IRE 在寡转移胰腺恶性肿瘤的多模态治疗中的应用。
Am J Surg. 2018 Jul;216(1):106-110. doi: 10.1016/j.amjsurg.2018.01.037. Epub 2018 Mar 3.
6
Irreversible electroporation in a case of pancreatic leiomyosarcoma: a novel weapon versus a rare malignancy?胰腺平滑肌肉瘤的不可逆电穿孔治疗:一种针对罕见肿瘤的新武器?
World J Surg Oncol. 2019 Jan 5;17(1):6. doi: 10.1186/s12957-018-1553-9.
7
Irreversible electroporation for pancreatic cancer using intraprocedural cone-beam computed tomography fusion navigation: a case report.使用术中锥形束计算机断层融合导航技术对胰腺癌进行不可逆电穿孔治疗:病例报告。
J Med Case Rep. 2021 Nov 25;15(1):566. doi: 10.1186/s13256-021-03152-2.
8
Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report.经皮不可逆电穿孔治疗无法手术切除的胰腺癌:一例报告。
J Vasc Interv Radiol. 2012 Jan;23(1):142-5. doi: 10.1016/j.jvir.2011.10.002.
9
Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?不可逆电穿孔治疗肝胆胰癌症安全有效吗?
Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):117-124. doi: 10.1016/j.hbpd.2019.01.001. Epub 2019 Jan 4.
10
Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.经皮不可逆电穿孔联合异基因自然杀伤细胞免疫疗法治疗不可切除(III/IV期)胰腺癌患者:一种有前景的治疗方法。
J Cancer Res Clin Oncol. 2017 Dec;143(12):2607-2618. doi: 10.1007/s00432-017-2513-4. Epub 2017 Sep 4.

引用本文的文献

1
Irreversible electroporation for metastatic pancreatic carcinoma with liver metastasis: What does the evidence say.不可逆电穿孔治疗转移性胰腺癌伴肝转移:证据如何。
World J Clin Cases. 2025 Jan 26;13(3):98452. doi: 10.12998/wjcc.v13.i3.98452.
2
FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577.FGD5-AS1 在胰腺癌中是一种致癌的 lncRNA,通过 miR-577 调节 Wnt/β-catenin 信号通路。
Oncol Rep. 2022 Jan;47(1). doi: 10.3892/or.2021.8232. Epub 2021 Nov 25.
3
Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

本文引用的文献

1
Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study.不可逆电穿孔联合化疗治疗不可切除胰腺癌:一项前瞻性队列研究。
Onco Targets Ther. 2019 Feb 18;12:1341-1350. doi: 10.2147/OTT.S186721. eCollection 2019.
2
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.IRE 在寡转移胰腺恶性肿瘤的多模态治疗中的应用。
基于自然杀伤细胞的免疫疗法与不可逆电穿孔联合治疗肝细胞癌
Ann Transl Med. 2021 Jul;9(13):1089. doi: 10.21037/atm-21-539.
4
Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma.丝束蛋白-3是胰腺腺癌的一种诊断和预后标志物,可与弥漫性大B细胞淋巴瘤相鉴别。
Cancer Cell Int. 2021 Aug 4;21(1):411. doi: 10.1186/s12935-021-02117-1.
5
Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America.电穿孔作为兽医学中癌症免疫治疗策略:拉丁美洲的现状
Vaccines (Basel). 2020 Sep 17;8(3):537. doi: 10.3390/vaccines8030537.
Am J Surg. 2018 Jul;216(1):106-110. doi: 10.1016/j.amjsurg.2018.01.037. Epub 2018 Mar 3.
4
S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials.吉西他滨难治性晚期胰腺癌中S-1单药治疗与S-1联合治疗的对比:一项随机对照试验的荟萃分析(PRISMA)
Medicine (Baltimore). 2017 Jul;96(30):e7611. doi: 10.1097/MD.0000000000007611.
5
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.不可逆电穿孔(IRE)在局部晚期胰腺癌中的作用:安全性和有效性的系统评价
Scand J Gastroenterol. 2017 Nov;52(11):1165-1171. doi: 10.1080/00365521.2017.1346705. Epub 2017 Jul 7.
6
A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas.一种用于胰腺头部和体部肿瘤微创不可逆电穿孔的新技术。
Surg Endosc. 2017 Apr;31(4):1982-1985. doi: 10.1007/s00464-016-5173-6. Epub 2016 Aug 29.
7
Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.局部晚期胰腺癌的不可逆电穿孔:呼吁能量传递标准化。
J Surg Oncol. 2016 Dec;114(7):865-871. doi: 10.1002/jso.24404. Epub 2016 Aug 21.
8
Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).不可逆电穿孔(IRE)治疗Child-Pugh B级(7/8分)肝细胞癌(HCC)的耐受性和疗效评估。
HPB (Oxford). 2016 Jul;18(7):593-9. doi: 10.1016/j.hpb.2016.03.609. Epub 2016 May 1.
9
Surgery for oligometastasis of pancreatic cancer.胰腺癌寡转移灶的手术治疗。
Chin J Cancer Res. 2015 Aug;27(4):358-67. doi: 10.3978/j.issn.1000-9604.2015.05.02.
10
Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.200 例局部晚期(III 期)胰腺腺癌患者接受不可逆电穿孔治疗的安全性和有效性。
Ann Surg. 2015 Sep;262(3):486-94; discussion 492-4. doi: 10.1097/SLA.0000000000001441.